Cartesian Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Frederick, MD
RNAC chart
What traders are saying about $RNAC
Latest postsCartesian Therapeutics, Inc. news
- Weekly Recap: Q3 results and Descartes-08 12-month retreatment data
TradingView ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- Barclays PLC Submits Amended Schedule 13G Revealing Stake in Cartesian Therapeutics
Kalkine Media ·
- Cartesian Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
marketscreener.com ·
- Cartesian Therapeutics earnings beat by $0.63, revenue topped estimates
Investing.com ·
- Cartesian Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Cartesian Therapeutics Q3 net loss narrows
TradingView ·
- Cartesian Therapeutics 3Q 2026: Revenue $0, EPS ($0.38) — 10-Q Summary
TradingView ·
- Revenue fell from $1.85M at Cartesian Therapeutics (RNAC) as operating cash use rose.
Stock Titan ·
- Cartesian Therapeutics Reports Q3 2026 Results, $124.7 Million in Cash
TradingView ·
- Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Cartesian Therapeutics reports Q3 2026 results; Phase 3 trial data for Descartes-08 in MG expected Q1 2027.
Pluang ·
Cartesian Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $400,000 | $38.3M | $26.0M | $110.8M |
| Net income | -$130.3M | -$77.4M | -$219.7M | $35.4M |
| Diluted EPS | $-5.02 | $-4.49 | $-49.76 | $0.10 |
| Total assets (year end) | $296.4M | $435.0M | $305.1M | $165.9M |
| Cash and equivalents (year end) | $125.1M | $212.6M | $76.9M | $106.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cartesian Therapeutics, Inc.
- Ticker
- RNAC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Frederick, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1453687
- Former names
- SELECTA BIOSCIENCES INC
Frequently asked questions
What exchange is Cartesian Therapeutics, Inc. listed on?
Cartesian Therapeutics, Inc. trades on the Nasdaq under the ticker symbol RNAC.
What industry is Cartesian Therapeutics, Inc. in?
Cartesian Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Cartesian Therapeutics, Inc. headquartered?
Cartesian Therapeutics, Inc.'s business address on file with the SEC is in Frederick, MD.
When does Cartesian Therapeutics, Inc.'s fiscal year end?
Cartesian Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Cartesian Therapeutics, Inc. report?
Cartesian Therapeutics, Inc. reported $400,000 in revenue for calendar year 2025, according to its SEC filings.